BY JOSEPH GUSTAITIS | JUNE 10, 2022 A while back we reported on how a medication (brand name Trulicity) created to treat one illness (diabetes) had been shown to be effective in treating another (heart disease). Now, according to research just published in the medical journal JAMA Ophthalmology, we now have another instance of a medication meant for...
Michael Marshall After a COVID-19 infection, some people have recovered their ability to perceive odours thanks to smell training. Credit: Fabio Bucciarelli/The New York Times/eyevine Researchers are finally making headway in understanding how the SARS-CoV-2 coronavirus causes loss of smell. And a multitude of potential treatments to tackle the condition are undergoing clinical trials, including...
By Neha Mathur Jun 13 2022 Reviewed by Danielle Ellis, B.Sc. In a recent study posted to the medRxiv* pre-print server, researchers in Israel compared the short-term effects of the first and second booster doses of messenger ribonucleic acid (mRNA-based) coronavirus disease 2019 (COVID-19) vaccine BNT162b2. Study: Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine....
Microencapsulation in biodegradable polymers allows drugs such as peptide therapeutics to be released over time in the body. Peptides are molecules in the body that are composed of short chains of amino acids, and include messengers, growth factors, and well-known hormones such as insulin. Because of their larger size and structure, peptide drugs are rarely given...
by German Center for Neurodegenerative Diseases Graphical abstract. Credit: Cell Reports Medicine (2022). DOI: 10.1016/j.xcrm.2022.100652 Recovery from severe COVID-19 is characterized by a reduction of certain white blood cells and changes in the molecular regulation of the immune system. This is the conclusion of an international research team coordinated by DZNE, which reports on this in the...
Whatever you are doing, whether it is driving a car, going for a jog, or even at your laziest, eating chips and watching TV on the couch, there is an entire suite of molecular machinery inside each of your cells hard at work. That machinery, far too small to see with the naked eye or...
Researchers at the University of California San Diego and the Salk Institute for Biological Studies have developed a tiny neural probe implanted for longer periods to record and stimulate neural activity while minimizing injury to the surrounding tissue. The new neural probe, detailed in a paper published in Nature Communications, is extremely thin—about one-fifth the width of a human hair—and...
JUNE 13TH, 2022 CONN HASTINGS CARDIAC SURGERY, CARDIOLOGY, MEDICINE, NANOMEDICINE Researchers at the University of Texas at Austin created a nanocarrier for stem cell factor, a regenerative cytokine. The nanotechnological approach renders the treatment much safer, as previous attempts to use stem cell factor as a pro-angiogenic treatment have been hampered by severe allergic reactions...
THE ENDOCRINE SOCIETY Patients with type 2 diabetes have an increased risk for fractures, despite their normal-to-high bone mineral density, according to research being presented Saturday, June 11 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga. “Patients using insulin or sulfonylurea are at a high risk of fractures compared to metformin-only users,...
THE ENDOCRINE SOCIETY The diabetes drug empagliflozin may decrease the risk of kidney stones in patients with type 2 diabetes, according to a new study presented Sunday, June 12 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga. Diabetes is a well-known risk factor for kidney stones. Empagliflozin (Jardiance) is an SGLT2 inhibitor....
